Training new investigators is a core mission of the Vasculitis Clinical Research Consortium (VCRC) and of high-priority to the Vasculitis Foundation (VF). The VCRC-VF Fellowship Program has been extremely successful. During the two initial 5-year grant periods, the VCRC recruited and provided salary support for 9 VCRC Fellows for two-year structured fellowships, all of whom remain in academic medicine, are specifically focused on caring for patients with vasculitis, and are engaged in clinical research in vasculitis. The VCRC-VF Fellowship is a structured, mentored training program of up to two years for physician-investigators who have developed an interest in vasculitis and wish to pursue a period of specialized training with an emphasis on translational and patient-oriented clinical investigation. The trainee undertakes the fellowship at one of the VCRC clinical research sites. Fellows who have developed an interest in vasculitis are recruited from Rheumatology, Nephrology, Pulmonology, Neurology, Vascular Medicine/Cardiology or other subspecialties. The Fellowship involves conduct of hypothesis-based clinical research in vasculitis, limited clinical experience focused on care of patients with vasculitis, and coursework directed at acquiring advanced skills in clinical research methodology. We propose to maintain the same careful approach to applicant selection and comprehensive training we have refined in the past decade, but will expand the number of Fellows and the number of VCRC Centers eligible to host VCRC Fellows. The VCRC-VF Fellowship will have additional generous financial support from the VF. The VCRC-VF Fellowship addresses the need to train more physicians in the care of patients with vasculitis and to develop a new generation of vasculitis clinical investigators.
The VCRC-VF Fellowship provides support for a 2-year program to train physicians in the care of patients with vasculitis and to provide the Fellows with additional advanced training in clinical research in vasculitis. This program will be a combine effort of the Vasculitis Clinical Research Consortium and the Vasculitis Foundation.
|Kermani, Tanaz A; Sreih, Antoine G; Cuthbertson, David et al. (2018) Evaluation of damage in giant cell arteritis. Rheumatology (Oxford) 57:322-328|
|Springer, Jason Michael; Monach, Paul; Cuthbertson, David et al. (2018) Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. J Clin Rheumatol 24:393-395|
|Robson, Joanna C; Dawson, Jill; Cronholm, Peter F et al. (2018) Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure. Patient Relat Outcome Meas 9:17-34|
|Grayson, Peter C; Eddy, Sean; Taroni, Jaclyn N et al. (2018) Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis 77:1226-1233|
|Barra, Lillian; Borchin, Renée L; Burroughs, Cristina et al. (2018) Impact of vasculitis on employment and income. Clin Exp Rheumatol 36 Suppl 111:58-64|
|Robson, Joanna C; Dawson, Jill; Doll, Helen et al. (2018) Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis 77:1157-1164|
|Sreih, Antoine G; Alibaz-Oner, Fatma; Easley, Ebony et al. (2018) Health-related outcomes of importance to patients with Takayasu's arteritis. Clin Exp Rheumatol 36 Suppl 111:51-57|
|Sreih, Antoine G; Ezzedine, Rana; Leng, Lin et al. (2018) Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis Rheumatol 70:2077-2086|
|Kermani, Tanaz A; Diab, Sehriban; Sreih, Antoine G et al. (2018) Arterial lesions in giant cell arteritis: A longitudinal study. Semin Arthritis Rheum :|
|Quinn, Kaitlin A; Ahlman, Mark A; Malayeri, Ashkan A et al. (2018) Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. Ann Rheum Dis 77:1165-1171|
Showing the most recent 10 out of 88 publications